Fostamatinib
Generic name: Pronounced as (fos" ta ma' ti nib)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 05/15/2018
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment. Fostamatinib is in a class of medications called kinase inhibitors. It works by reducing platelet destruction.
How should this medicine be used?
Fostamatinib comes as a tablet to take by mouth. It is usually taken with or without food twice daily. Take fostamatinib at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take fostamatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Your doctor may need to reduce, interrupt, or discontinue your treatment if you experience certain side effects or depending on your treatment response. If your number of platelets (platelet count) does not increase to a certain level after 12 weeks of treatment, your doctor may have to discontinue your treatment. Talk to your doctor about how you are feeling during your treatment.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking fostamatinib,
-
tell your doctor and pharmacist if you are allergic to fostamatinib, any other medications, or any of the ingredients in fostamatinib tablets. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: clarithromycin (Biaxin, in Prevpac), digoxin (Lanoxin), itraconazole (Onmel, Sporanox), ketoconazole, rifampin (Rifadin, Rimactane, in Rifamate, in Rifater), and rosuvastatin (Crestor). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with fostamatinib, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.
-
tell your doctor if you have or have ever had high blood pressure or liver disease.
-
tell your doctor if you are pregnant or plan to become pregnant. You will need to have a pregnancy test before you start treatment, and you should use birth control to prevent pregnancy during your fostamatinib treatment and for at least 1 month after your final dose. Talk to your doctor about birth control methods that you can use. If you become pregnant, call your doctor immediately. Fostamatinib may harm the fetus.
-
tell your doctor if you are breastfeeding. You should not breastfeed during your treatment with fostamatinib and for at least 1 month after your final dose.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Fostamatinib may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
diarrhea
-
nausea
-
dizziness
-
rash
-
abdominal pain
-
fatigue
-
-
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:
-
severe diarrhea
-
headache, confusion, dizziness, chest pain, or shortness of breath
-
pain in the upper right part of the stomach
-
yellowing of the skin or eyes
-
dark colored urine
-
nausea
-
vomiting
-
-
Fostamatinib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Do not remove the desiccant canisters (a small canister that contains a substance that absorbs moisture to keep the medication dry).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to fostamatinib. Your doctor will also check your blood pressure regularly during your treatment with fostamatinib.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Leflunomide | Leflunomide Fostamatinib may decrease the excretion rate of Leflunomide which could result in a higher serum level. |
Atorvastatin | Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Fostamatinib. |
Aminophylline | Aminophylline The metabolism of Aminophylline can be decreased when combined with Fostamatinib. |
Candesartan | Candesartan Fostamatinib may increase the antihypertensive activities of Candesartan. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Fostamatinib. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Fostamatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Fostamatinib. |
Guanfacine | Guanfacine Fostamatinib may increase the antihypertensive activities of Guanfacine. |
Mycophenolate | Mycophenolate The metabolism of Mycophenolic acid can be decreased when combined with Fostamatinib. |
Paregoric | Paregoric The metabolism of Morphine can be decreased when combined with Fostamatinib. |
Penbutolol | Penbutolol Fostamatinib may increase the antihypertensive activities of Acebutolol. |
Reserpine | Reserpine Fostamatinib may increase the antihypertensive activities of Reserpine. |
Sumatriptan | Sumatriptan Fostamatinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level. |
Tacrolimus | Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Fostamatinib. |
Tizanidine | Tizanidine The risk or severity of hypotension can be increased when Fostamatinib is combined with Tizanidine. |
Meperidine Injection | Meperidine Injection The metabolism of Meperidine can be decreased when combined with Fostamatinib. |
Metronidazole Injection | Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Fostamatinib. |
Morphine Injection | Morphine Injection The metabolism of Morphine can be decreased when combined with Fostamatinib. |
Zidovudine Injection | Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Fostamatinib. |
Cyclosporine | Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Fostamatinib. |
Torsemide | Torsemide Fostamatinib may increase the antihypertensive activities of Torasemide. |
Olanzapine | Olanzapine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Olanzapine. |
Dofetilide | Dofetilide The metabolism of Dofetilide can be decreased when combined with Fostamatinib. |
Eprosartan | Eprosartan Fostamatinib may increase the antihypertensive activities of Eprosartan. |
Telmisartan | Telmisartan Fostamatinib may increase the antihypertensive activities of Telmisartan. |
Trimipramine | Trimipramine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Trimipramine. |
Perindopril | Perindopril Fostamatinib may increase the antihypertensive activities of Perindopril. |
Tenofovir | Tenofovir The metabolism of Tenofovir can be decreased when combined with Fostamatinib. |
Sirolimus | Sirolimus The metabolism of Sirolimus can be decreased when combined with Fostamatinib. |
Eplerenone | Eplerenone Fostamatinib may increase the antihypertensive activities of Eplerenone. |
Olmesartan | Olmesartan Fostamatinib may increase the antihypertensive activities of Olmesartan. |
Zonisamide | Zonisamide The metabolism of Zonisamide can be decreased when combined with Fostamatinib. |
Aripiprazole | Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Fostamatinib. |
Ezetimibe | Ezetimibe The metabolism of Ezetimibe can be decreased when combined with Fostamatinib. |
Teriparatide Injection | Teriparatide Injection The therapeutic efficacy of Teriparatide can be decreased when used in combination with Fostamatinib. |
Atazanavir | Atazanavir The metabolism of Atazanavir can be decreased when combined with Fostamatinib. |
Rosuvastatin | Rosuvastatin Fostamatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level. |
Vardenafil | Vardenafil The metabolism of Vardenafil can be decreased when combined with Fostamatinib. |
Alfuzosin | Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Fostamatinib. |
Tegaserod | Tegaserod Fostamatinib may decrease the excretion rate of Tegaserod which could result in a higher serum level. |
Tadalafil | Tadalafil The risk or severity of adverse effects can be increased when Fostamatinib is combined with Tadalafil. |
Apomorphine Injection | Apomorphine Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Apomorphine. |
Duloxetine | Duloxetine The metabolism of Duloxetine can be decreased when combined with Fostamatinib. |
Norethindrone | Norethindrone The metabolism of Norethisterone can be decreased when combined with Fostamatinib. |
Bosentan | Bosentan Fostamatinib may increase the antihypertensive activities of Bosentan. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Fostamatinib. |
Eszopiclone | Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Fostamatinib. |
Isocarboxazid | Isocarboxazid The risk or severity of hypotension can be increased when Fostamatinib is combined with Isocarboxazid. |
Fentanyl | Fentanyl The metabolism of Fentanyl can be decreased when combined with Fostamatinib. |
Deferasirox | Deferasirox The metabolism of Fostamatinib can be decreased when combined with Deferasirox. |
Phenylephrine | Phenylephrine The risk or severity of hypertension can be decreased when Fostamatinib is combined with Phenylephrine. |
Rasagiline | Rasagiline The risk or severity of hypotension can be increased when Fostamatinib is combined with Rasagiline. |
Imatinib | Imatinib Fostamatinib may decrease the excretion rate of Imatinib which could result in a higher serum level. |
Gefitinib | Gefitinib Fostamatinib may decrease the excretion rate of Gefitinib which could result in a higher serum level. |
Paliperidone | Paliperidone The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Paliperidone. |
Bortezomib | Bortezomib The metabolism of Bortezomib can be decreased when combined with Fostamatinib. |
Clofarabine Injection | Clofarabine Injection Fostamatinib may decrease the excretion rate of Clofarabine which could result in a higher serum level. |
Fulvestrant Injection | Fulvestrant Injection The metabolism of Fulvestrant can be decreased when combined with Fostamatinib. |
Oxaliplatin Injection | Oxaliplatin Injection Fostamatinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level. |
Aliskiren | Aliskiren Fostamatinib may increase the antihypertensive activities of Aliskiren. |
Nabilone | Nabilone The risk or severity of hypotension can be increased when Fostamatinib is combined with Nabilone. |
Retapamulin | Retapamulin The metabolism of Retapamulin can be decreased when combined with Fostamatinib. |
Sorafenib | Sorafenib The metabolism of Fostamatinib can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The metabolism of Sunitinib can be decreased when combined with Fostamatinib. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Fostamatinib. |
Ivermectin | Ivermectin Fostamatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level. |
Temsirolimus | Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Fostamatinib. |
Nilotinib | Nilotinib The metabolism of Nilotinib can be decreased when combined with Fostamatinib. |
Raltegravir | Raltegravir The metabolism of Raltegravir can be decreased when combined with Fostamatinib. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Arsenic trioxide. |
Mitoxantrone Injection | Mitoxantrone Injection Fostamatinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level. |
Sapropterin | Sapropterin Sapropterin may increase the hypotensive activities of Fostamatinib. |
Nebivolol | Nebivolol Fostamatinib may increase the antihypertensive activities of Nebivolol. |
Tretinoin | Tretinoin The risk or severity of hypotension can be increased when Fostamatinib is combined with Tretinoin. |
Ixabepilone Injection | Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Fostamatinib. |
Irinotecan Injection | Irinotecan Injection The risk or severity of neutropenia can be increased when Fostamatinib is combined with Irinotecan. |
Rufinamide | Rufinamide The metabolism of Rufinamide can be decreased when combined with Fostamatinib. |
Silodosin | Silodosin The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Silodosin. |
Midazolam | Midazolam The serum concentration of Midazolam can be increased when it is combined with Fostamatinib. |
Naltrexone Injection | Naltrexone Injection The metabolism of Naltrexone can be decreased when combined with Fostamatinib. |
Eltrombopag | Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Fostamatinib. |
Betaxolol | Betaxolol Fostamatinib may increase the antihypertensive activities of Betaxolol. |
Iloperidone | Iloperidone The metabolism of Iloperidone can be decreased when combined with Fostamatinib. |
Lacosamide | Lacosamide The metabolism of Lacosamide can be decreased when combined with Fostamatinib. |
Everolimus | Everolimus The metabolism of Everolimus can be decreased when combined with Fostamatinib. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Fostamatinib. |
Dronedarone | Dronedarone The metabolism of Dronedarone can be decreased when combined with Fostamatinib. |
Pralatrexate Injection | Pralatrexate Injection Fostamatinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Romidepsin Injection | Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Fostamatinib. |
Topotecan | Topotecan Fostamatinib may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Fostamatinib. |
Asenapine | Asenapine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Asenapine. |
Pitavastatin | Pitavastatin Fostamatinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level. |
Albendazole | Albendazole The metabolism of Albendazole can be decreased when combined with Fostamatinib. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Fostamatinib. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Fostamatinib. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Aldesleukin. |
Azilsartan | Azilsartan The risk or severity of hypotension can be increased when Fostamatinib is combined with Azilsartan medoxomil. |
Busulfan Injection | Busulfan Injection The metabolism of Busulfan can be decreased when combined with Fostamatinib. |
Roflumilast | Roflumilast The metabolism of Roflumilast can be decreased when combined with Fostamatinib. |
Linagliptin | Linagliptin The metabolism of Linagliptin can be decreased when combined with Fostamatinib. |
Telaprevir | Telaprevir Fostamatinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level. |
Potassium Iodide | Potassium Iodide The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Fostamatinib. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Fostamatinib. |
Rivaroxaban | Rivaroxaban Fostamatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Fostamatinib. |
Ruxolitinib | Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Fostamatinib. |
Vandetanib | Vandetanib The metabolism of Vandetanib can be decreased when combined with Fostamatinib. |
Vemurafenib | Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Fostamatinib. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Fostamatinib. |
Crizotinib | Crizotinib The metabolism of Crizotinib can be decreased when combined with Fostamatinib. |
Cabergoline | Cabergoline The metabolism of Cabergoline can be decreased when combined with Fostamatinib. |
Naloxone Injection | Naloxone Injection The metabolism of Naloxone can be decreased when combined with Fostamatinib. |
Ambrisentan | Ambrisentan Fostamatinib may increase the antihypertensive activities of Ambrisentan. |
Ezogabine | Ezogabine The metabolism of Tiagabine can be decreased when combined with Fostamatinib. |
Iloprost | Iloprost The risk or severity of hypotension can be increased when Fostamatinib is combined with Iloprost. |
Regorafenib | Regorafenib The metabolism of Fostamatinib can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The metabolism of Bosutinib can be decreased when combined with Fostamatinib. |
Teriflunomide | Teriflunomide Fostamatinib may decrease the excretion rate of Teriflunomide which could result in a higher serum level. |
Tofacitinib | Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Fostamatinib. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Fostamatinib. |
Pomalidomide | Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Fostamatinib. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Fostamatinib. |
Apixaban | Apixaban Fostamatinib may decrease the excretion rate of Apixaban which could result in a higher serum level. |
Canagliflozin | Canagliflozin The risk or severity of hypotension can be increased when Fostamatinib is combined with Canagliflozin. |
Methazolamide | Methazolamide The risk or severity of hypotension can be increased when Fostamatinib is combined with Methazolamide. |
Dabrafenib | Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Fostamatinib. |
Dolutegravir | Dolutegravir The metabolism of Dolutegravir can be decreased when combined with Fostamatinib. |
Afatinib | Afatinib Fostamatinib may decrease the excretion rate of Afatinib which could result in a higher serum level. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Fostamatinib. |
Lomitapide | Lomitapide The metabolism of Lomitapide can be decreased when combined with Fostamatinib. |
Avanafil | Avanafil The risk or severity of adverse effects can be increased when Avanafil is combined with Fostamatinib. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Obinutuzumab. |
Simeprevir | Simeprevir Fostamatinib may decrease the excretion rate of Simeprevir which could result in a higher serum level. |
Sofosbuvir | Sofosbuvir Fostamatinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin The risk or severity of hypotension can be increased when Fostamatinib is combined with Dapagliflozin. |
Ceritinib | Ceritinib The metabolism of Ceritinib can be decreased when combined with Fostamatinib. |
Eslicarbazepine | Eslicarbazepine The metabolism of Eslicarbazepine can be decreased when combined with Fostamatinib. |
Belinostat Injection | Belinostat Injection The metabolism of Belinostat can be decreased when combined with Fostamatinib. |
Idelalisib | Idelalisib The metabolism of Idelalisib can be decreased when combined with Fostamatinib. |
Testosterone Injection | Testosterone Injection Fostamatinib may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Empagliflozin | Empagliflozin The risk or severity of hypotension can be increased when Fostamatinib is combined with Empagliflozin. |
Vorapaxar | Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Fostamatinib. |
Suvorexant | Suvorexant The metabolism of Suvorexant can be decreased when combined with Fostamatinib. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Fostamatinib. |
Tasimelteon | Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Fostamatinib. |
Riociguat | Riociguat Fostamatinib may increase the hypotensive activities of Riociguat. |
Nintedanib | Nintedanib The metabolism of Nintedanib can be decreased when combined with Fostamatinib. |
Risperidone Injection | Risperidone Injection The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Risperidone. |
Palbociclib | Palbociclib The metabolism of Palbociclib can be decreased when combined with Fostamatinib. |
Lenvatinib | Lenvatinib Fostamatinib may decrease the excretion rate of Lenvatinib which could result in a higher serum level. |
Panobinostat | Panobinostat The metabolism of Panobinostat can be decreased when combined with Fostamatinib. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Fostamatinib. |
Amiloride | Amiloride The risk or severity of hypotension can be increased when Fostamatinib is combined with Amiloride. |
Macitentan | Macitentan Fostamatinib may increase the antihypertensive activities of Macitentan. |
Sonidegib | Sonidegib The metabolism of Sonidegib can be decreased when combined with Fostamatinib. |
Brexpiprazole | Brexpiprazole The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Ziprasidone. |
Cobimetinib | Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Fostamatinib. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Fostamatinib. |
Osimertinib | Osimertinib The metabolism of Osimertinib can be decreased when combined with Fostamatinib. |
Alectinib | Alectinib The metabolism of Alectinib can be decreased when combined with Fostamatinib. |
Ixazomib | Ixazomib The metabolism of Ixazomib can be decreased when combined with Fostamatinib. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Amphotericin B. |
Venetoclax | Venetoclax The metabolism of Venetoclax can be decreased when combined with Fostamatinib. |
Selexipag | Selexipag Fostamatinib may increase the antihypertensive activities of Selexipag. |
Furosemide Injection | Furosemide Injection The metabolism of Furosemide can be decreased when combined with Fostamatinib. |
Rucaparib | Rucaparib Fostamatinib may decrease the excretion rate of Rucaparib which could result in a higher serum level. |
Ribociclib | Ribociclib The metabolism of Ribociclib can be decreased when combined with Fostamatinib. |
Parathyroid Hormone Injection | Parathyroid Hormone Injection The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Fostamatinib. |
Brigatinib | Brigatinib The metabolism of Brigatinib can be decreased when combined with Fostamatinib. |
Doxepin (Insomnia) | Doxepin (Insomnia) The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Doxepin. |
Midostaurin | Midostaurin The metabolism of Midostaurin can be decreased when combined with Fostamatinib. |
Neratinib | Neratinib The metabolism of Neratinib can be decreased when combined with Fostamatinib. |
Abaloparatide Injection | Abaloparatide Injection The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Fostamatinib. |
Enasidenib | Enasidenib The metabolism of Enasidenib can be decreased when combined with Fostamatinib. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Fostamatinib. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Fostamatinib. |
Delafloxacin | Delafloxacin The metabolism of Delafloxacin can be decreased when combined with Fostamatinib. |
Abemaciclib | Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Fostamatinib. |
Acalabrutinib | Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Fostamatinib. |
Letermovir | Letermovir The metabolism of Letermovir can be decreased when combined with Fostamatinib. |
Ertugliflozin | Ertugliflozin Fostamatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level. |
Buprenorphine Injection | Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Fostamatinib. |
Baricitinib | Baricitinib The metabolism of Baricitinib can be decreased when combined with Fostamatinib. |
Lofexidine | Lofexidine Fostamatinib may increase the antihypertensive activities of Lofexidine. |
Eliglustat | Eliglustat The metabolism of Eliglustat can be decreased when combined with Fostamatinib. |
Binimetinib | Binimetinib The metabolism of Binimetinib can be decreased when combined with Fostamatinib. |
Ivosidenib | Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Fostamatinib. |
Lusutrombopag | Lusutrombopag Fostamatinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Fostamatinib. |
Dacomitinib | Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Fostamatinib. |
Duvelisib | Duvelisib Fostamatinib may decrease the excretion rate of Duvelisib which could result in a higher serum level. |
Talazoparib | Talazoparib Fostamatinib may decrease the excretion rate of Talazoparib which could result in a higher serum level. |
Gilteritinib | Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Fostamatinib. |
Glasdegib | Glasdegib Fostamatinib may decrease the excretion rate of Glasdegib which could result in a higher serum level. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Fostamatinib. |
Prucalopride | Prucalopride The metabolism of Prucalopride can be decreased when combined with Fostamatinib. |
Siponimod | Siponimod The metabolism of Siponimod can be decreased when combined with Fostamatinib. |
Erdafitinib | Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Fostamatinib. |
Alpelisib | Alpelisib The serum concentration of Alpelisib can be increased when it is combined with Fostamatinib. |
Cladribine | Cladribine Fostamatinib may decrease the excretion rate of Cladribine which could result in a higher serum level. |
Darolutamide | Darolutamide Fostamatinib may decrease the excretion rate of Darolutamide which could result in a higher serum level. |
Entrectinib | Entrectinib The metabolism of Entrectinib can be decreased when combined with Fostamatinib. |
Pexidartinib | Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Fostamatinib. |
Pitolisant | Pitolisant The serum concentration of Fostamatinib can be decreased when it is combined with Pitolisant. |
Lefamulin | Lefamulin The metabolism of Lefamulin can be decreased when combined with Fostamatinib. |
Phenytoin Injection | Phenytoin Injection The metabolism of Fostamatinib can be decreased when combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Fostamatinib. |
Zanubrutinib | Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Fostamatinib. |
Voxelotor | Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Fostamatinib. |
Lumateperone | Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Fostamatinib. |
Ubrogepant | Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Fostamatinib. |
Tazemetostat | Tazemetostat Fostamatinib may decrease the excretion rate of Tazemetostat which could result in a higher serum level. |
Cenobamate | Cenobamate The serum concentration of Fostamatinib can be decreased when it is combined with Cenobamate. |
Ozanimod | Ozanimod Fostamatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level. |
Selumetinib | Selumetinib Fostamatinib may decrease the excretion rate of Selumetinib which could result in a higher serum level. |
Rimegepant | Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Fostamatinib. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Fostamatinib. |
Sacituzumab govitecan-hziy Injection | Sacituzumab govitecan-hziy Injection The serum concentration of Sacituzumab govitecan can be increased when it is combined with Fostamatinib. |
Ripretinib | Ripretinib Fostamatinib may decrease the excretion rate of Ripretinib which could result in a higher serum level. |
Fostemsavir | Fostemsavir Fostamatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level. |
Pralsetinib | Pralsetinib Fostamatinib may decrease the excretion rate of Pralsetinib which could result in a higher serum level. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Fostamatinib can be decreased when it is combined with Satralizumab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Fostamatinib. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Fostamatinib. |
Indomethacin | Indomethacin The metabolism of Indomethacin can be decreased when combined with Fostamatinib. |
Mefenamic Acid | Mefenamic Acid The metabolism of Fostamatinib can be decreased when combined with Mefenamic acid. |
Naproxen | Naproxen The metabolism of Naproxen can be decreased when combined with Fostamatinib. |
Trazodone | Trazodone The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Trazodone. |
Methotrexate Injection | Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Fostamatinib. |
Chlorpromazine | Chlorpromazine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Chlorpromazine. |
Lorazepam | Lorazepam The metabolism of Lorazepam can be decreased when combined with Fostamatinib. |
Phenoxybenzamine | Phenoxybenzamine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Phenoxybenzamine. |
Bromocriptine | Bromocriptine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Bromocriptine. |
Tranylcypromine | Tranylcypromine The risk or severity of hypotension can be increased when Fostamatinib is combined with Tranylcypromine. |
Phenelzine | Phenelzine The risk or severity of hypotension can be increased when Fostamatinib is combined with Phenelzine. |
Prochlorperazine | Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Fostamatinib. |
Thioridazine | Thioridazine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Trifluoperazine. |
Ibuprofen | Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Fostamatinib. |
Phentermine | Phentermine The metabolism of Phentermine can be decreased when combined with Fostamatinib. |
Amoxapine | Amoxapine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Amoxapine. |
Sulfasalazine | Sulfasalazine Fostamatinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Doxorubicin | Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Fostamatinib. |
Dactinomycin | Dactinomycin Fostamatinib may decrease the excretion rate of Dactinomycin which could result in a higher serum level. |
Carbamazepine | Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Fostamatinib. |
Methyldopa | Methyldopa Fostamatinib may increase the antihypertensive activities of Methyldopa. |
Clonidine | Clonidine The metabolism of Clonidine can be decreased when combined with Fostamatinib. |
Prazosin | Prazosin Fostamatinib may decrease the excretion rate of Prazosin which could result in a higher serum level. |
Hydralazine | Hydralazine Fostamatinib may increase the antihypertensive activities of Hydralazine. |
Warfarin | Warfarin The serum concentration of Warfarin can be increased when it is combined with Fostamatinib. |
Daunorubicin | Daunorubicin Fostamatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Fostamatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Triamterene | Triamterene The risk or severity of hypotension can be increased when Fostamatinib is combined with Triamterene. |
Chlorothiazide | Chlorothiazide Fostamatinib may increase the antihypertensive activities of Chlorothiazide. |
Chlorthalidone | Chlorthalidone Fostamatinib may increase the antihypertensive activities of Chlorthalidone. |
Metolazone | Metolazone Fostamatinib may increase the antihypertensive activities of Metolazone. |
Isosorbide | Isosorbide The risk or severity of hypotension can be increased when Fostamatinib is combined with Isosorbide. |
Amitriptyline | Amitriptyline The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Amitriptyline. |
Imipramine | Imipramine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Imipramine. |
Quinidine | Quinidine The metabolism of Quinidine can be decreased when combined with Fostamatinib. |
Rifampin | Rifampin The metabolism of Fostamatinib can be decreased when combined with Rifampicin. |
Valproic Acid | Valproic Acid The metabolism of Valproic acid can be decreased when combined with Fostamatinib. |
Tamoxifen | Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Fostamatinib. |
Levothyroxine | Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Fostamatinib. |
Liothyronine | Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Fostamatinib. |
Methimazole | Methimazole The therapeutic efficacy of Methimazole can be decreased when used in combination with Fostamatinib. |
Propylthiouracil | Propylthiouracil The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Fostamatinib. |
Methyclothiazide | Methyclothiazide The risk or severity of hypotension can be increased when Fostamatinib is combined with Methyclothiazide. |
Hydrochlorothiazide | Hydrochlorothiazide Fostamatinib may increase the antihypertensive activities of Hydrochlorothiazide. |
Folic Acid | Folic Acid Fostamatinib may decrease the excretion rate of Folic acid which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Fostamatinib may increase the antihypertensive activities of Propranolol. |
Minoxidil | Minoxidil The metabolism of Minoxidil can be decreased when combined with Fostamatinib. |
Nortriptyline | Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Fostamatinib. |
Spironolactone | Spironolactone The risk or severity of hypotension can be increased when Fostamatinib is combined with Spironolactone. |
Amphotericin B Injection | Amphotericin B Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Amphotericin B. |
Nadolol | Nadolol Fostamatinib may increase the antihypertensive activities of Nadolol. |
Allopurinol | Allopurinol Fostamatinib may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Papaverine | Papaverine The risk or severity of hypotension can be increased when Fostamatinib is combined with Papaverine. |
Fluorouracil Injection | Fluorouracil Injection Fostamatinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level. |
Colchicine | Colchicine The metabolism of Colchicine can be decreased when combined with Fostamatinib. |
Cephalexin | Cephalexin The metabolism of Cephalexin can be decreased when combined with Fostamatinib. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fostamatinib. |
Thiotepa Injection | Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Fostamatinib. |
Vincristine Injection | Vincristine Injection The metabolism of Vincristine can be decreased when combined with Fostamatinib. |
Captopril | Captopril Fostamatinib may increase the antihypertensive activities of Captopril. |
Dipyridamole | Dipyridamole The risk or severity of adverse effects can be increased when Dipyridamole is combined with Fostamatinib. |
Isoxsuprine | Isoxsuprine The risk or severity of hypotension can be increased when Fostamatinib is combined with Isoxsuprine. |
Vinblastine | Vinblastine The metabolism of Vinblastine can be decreased when combined with Fostamatinib. |
Ethacrynic Acid | Ethacrynic Acid The risk or severity of hypotension can be increased when Fostamatinib is combined with Etacrynic acid. |
Metoprolol | Metoprolol The metabolism of Metoprolol can be decreased when combined with Fostamatinib. |
Alprazolam | Alprazolam The metabolism of Alprazolam can be decreased when combined with Fostamatinib. |
Diltiazem | Diltiazem Fostamatinib may increase the antihypertensive activities of Diltiazem. |
Nifedipine | Nifedipine The risk or severity of hypotension can be increased when Fostamatinib is combined with Nifedipine. |
Timolol | Timolol Fostamatinib may increase the antihypertensive activities of Timolol. |
Verapamil | Verapamil The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Verapamil. |
Atenolol | Atenolol Fostamatinib may increase the antihypertensive activities of Atenolol. |
Pindolol | Pindolol Fostamatinib may increase the antihypertensive activities of Pindolol. |
Diflunisal | Diflunisal The metabolism of Fostamatinib can be decreased when combined with Diflunisal. |
Bumetanide | Bumetanide The risk or severity of hypotension can be increased when Fostamatinib is combined with Bumetanide. |
Etoposide | Etoposide The metabolism of Etoposide can be decreased when combined with Fostamatinib. |
Glyburide | Glyburide Fostamatinib may decrease the excretion rate of Glyburide which could result in a higher serum level. |
Glipizide | Glipizide The metabolism of Glipizide can be decreased when combined with Fostamatinib. |
Indapamide | Indapamide Fostamatinib may increase the antihypertensive activities of Indapamide. |
Pentoxifylline | Pentoxifylline The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Fostamatinib. |
Labetalol | Labetalol The metabolism of Labetalol can be decreased when combined with Fostamatinib. |
Gemfibrozil | Gemfibrozil The metabolism of Gemfibrozil can be decreased when combined with Fostamatinib. |
Guanabenz | Guanabenz Fostamatinib may increase the antihypertensive activities of Guanabenz. |
Ketoprofen | Ketoprofen The metabolism of Ketoprofen can be decreased when combined with Fostamatinib. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Fostamatinib. |
Enalapril | Enalapril Fostamatinib may increase the antihypertensive activities of Enalapril. |
Flurbiprofen | Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Fostamatinib. |
Amiodarone | Amiodarone The metabolism of Amiodarone can be decreased when combined with Fostamatinib. |
Lovastatin | Lovastatin The metabolism of Lovastatin can be decreased when combined with Fostamatinib. |
Diclofenac | Diclofenac The metabolism of Diclofenac can be decreased when combined with Fostamatinib. |
Nimodipine | Nimodipine Fostamatinib may increase the antihypertensive activities of Nimodipine. |
Clozapine | Clozapine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Clozapine. |
Benazepril | Benazepril Fostamatinib may increase the antihypertensive activities of Benazepril. |
Felodipine | Felodipine Fostamatinib may increase the antihypertensive activities of Felodipine. |
Fosinopril | Fosinopril Fostamatinib may increase the antihypertensive activities of Fosinopril. |
Pravastatin | Pravastatin Fostamatinib may decrease the excretion rate of Pravastatin which could result in a higher serum level. |
Quinapril | Quinapril Fostamatinib may increase the antihypertensive activities of Quinapril. |
Ramipril | Ramipril Fostamatinib may increase the antihypertensive activities of Ramipril. |
Simvastatin | Simvastatin The metabolism of Simvastatin can be decreased when combined with Fostamatinib. |
Amlodipine | Amlodipine Fostamatinib may increase the antihypertensive activities of Amlodipine. |
Teniposide Injection | Teniposide Injection The metabolism of Teniposide can be decreased when combined with Fostamatinib. |
Lisinopril | Lisinopril Fostamatinib may increase the antihypertensive activities of Lisinopril. |
Sotalol | Sotalol The risk or severity of hypotension can be increased when Fostamatinib is combined with Sotalol. |
Bisoprolol | Bisoprolol Fostamatinib may increase the antihypertensive activities of Bisoprolol. |
Doxazosin | Doxazosin The risk or severity of hypotension can be increased when Fostamatinib is combined with Doxazosin. |
Terazosin | Terazosin The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Terazosin. |
Isradipine | Isradipine Fostamatinib may increase the antihypertensive activities of Isradipine. |
Cisapride | Cisapride The metabolism of Cisapride can be decreased when combined with Fostamatinib. |
Fluvastatin | Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Fostamatinib. |
Famciclovir | Famciclovir The metabolism of Famciclovir can be decreased when combined with Fostamatinib. |
Nefazodone | Nefazodone The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Nefazodone. |
Lamotrigine | Lamotrigine The metabolism of Lamotrigine can be decreased when combined with Fostamatinib. |
Losartan | Losartan The metabolism of Losartan can be decreased when combined with Fostamatinib. |
Tramadol | Tramadol The metabolism of Tramadol can be decreased when combined with Fostamatinib. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Fostamatinib. |
Moexipril | Moexipril Fostamatinib may increase the antihypertensive activities of Moexipril. |
Alprostadil Urogenital | Alprostadil Urogenital The risk or severity of hypotension and priapism can be increased when Fostamatinib is combined with Alprostadil. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Fostamatinib. |
Nicardipine | Nicardipine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Nicardipine. |
Ticlopidine | Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Fostamatinib. |
Nisoldipine | Nisoldipine Fostamatinib may increase the antihypertensive activities of Nisoldipine. |
Lamivudine | Lamivudine Fostamatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Riluzole | Riluzole Fostamatinib may decrease the excretion rate of Riluzole which could result in a higher serum level. |
Amifostine Injection | Amifostine Injection The risk or severity of hypotension can be increased when Fostamatinib is combined with Amifostine. |
Ritonavir | Ritonavir The serum concentration of R406, an active metabolite of Ritonavir, can be increased when used in combination with Fostamatinib. |
Docetaxel Injection | Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Fostamatinib. |
Clomipramine | Clomipramine The metabolism of Clomipramine can be decreased when combined with Fostamatinib. |
Zafirlukast | Zafirlukast The metabolism of Fostamatinib can be decreased when combined with Zafirlukast. |
Trandolapril | Trandolapril Fostamatinib may increase the antihypertensive activities of Trandolapril. |
Valsartan | Valsartan Fostamatinib may increase the antihypertensive activities of Valsartan. |
Pramipexole | Pramipexole The risk or severity of hypotension can be increased when Fostamatinib is combined with Pramipexole. |
Donepezil | Donepezil Fostamatinib may decrease the excretion rate of Donepezil which could result in a higher serum level. |
Azithromycin | Azithromycin The metabolism of Azithromycin can be decreased when combined with Fostamatinib. |
Carvedilol | Carvedilol The metabolism of Carvedilol can be decreased when combined with Fostamatinib. |
Selegiline | Selegiline The risk or severity of hypotension can be increased when Fostamatinib is combined with Selegiline. |
Bicalutamide | Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Fostamatinib. |
Raloxifene | Raloxifene The metabolism of Raloxifene can be decreased when combined with Fostamatinib. |
Irbesartan | Irbesartan Fostamatinib may increase the antihypertensive activities of Irbesartan. |
Tamsulosin | Tamsulosin The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Tamsulosin. |
Ropinirole | Ropinirole The risk or severity of hypotension can be increased when Fostamatinib is combined with Ropinirole. |
Quetiapine | Quetiapine The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Quetiapine. |
Tolcapone | Tolcapone The risk or severity of hypotension can be increased when Fostamatinib is combined with Tolcapone. |
Abacavir | Abacavir The metabolism of Abacavir can be decreased when combined with Fostamatinib. |
Sildenafil | Sildenafil The risk or severity of adverse effects can be increased when Sildenafil is combined with Fostamatinib. |
Celecoxib | Celecoxib Fostamatinib may decrease the excretion rate of Celecoxib which could result in a higher serum level. |
Thalidomide | Thalidomide The risk or severity of hypotension can be increased when Fostamatinib is combined with Thalidomide. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists